Ignite Creation Date:
2024-05-11 @ 8:30 AM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06407310
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-09
First Post:
2024-03-04
Brief Title:
Neoadjuvant Pembrolizumab Carboplatin and Paclitaxel in Triple-negative Breast Cancer
Sponsor:
Tel Aviv Medical Center
Organization:
Tel Aviv Medical Center
Organization Data
Organization:
Tel Aviv Medical Center
Class:
OTHER
Study ID:
0617-22 TLV
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Tel Aviv Medical Center
Lead Sponsor Class:
OTHER
Responsible Party:
Yasmin Leshem
Responsible Party Title:
Senior Medical Oncologist
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Tel Aviv Medical Center
Old Name:
None
Old Organization:
None